Document is current
Any future updates will be listed below
-
Authors
Leube, Julian https://orcid.org/0000-0002-1849-5860
Gustafsson, Johan
Lassmann, Michael
Salas-Ramirez, Maikol
Tran-Gia, Johannes
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TR 1380/1-1)
Swedish Cancer Foundation (180747, 21 1754 Pj 01 H)
Fru Berta Kamprads Stiftelse (FBKS 2019-44, FBKS 2020-13)
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 4 April 2022
Accepted: 3 July 2022
First Online: 19 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: M. Lassmann has received research Grants by IPSEN Pharma and Nordic Nanovector. No other potential conflicts of interest relevant to this article exist.
